Infant Bacterial Therapeutics AB (OSTO:IBT B) Other Stockholders Equity : kr-0.00 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Infant Bacterial Therapeutics AB Other Stockholders Equity?

Infant Bacterial Therapeutics AB's Other Stockholders Equity for the quarter that ended in Dec. 2024 was kr-0.00 Mil.

Infant Bacterial Therapeutics AB's quarterly Other Stockholders Equity declined from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr-0.00 Mil) but then stayed the same from Sep. 2024 (kr-0.00 Mil) to Dec. 2024 (kr-0.00 Mil).

Infant Bacterial Therapeutics AB's annual Other Stockholders Equity increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) but then declined from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr-0.00 Mil).

Infant Bacterial Therapeutics AB Other Stockholders Equity Historical Data

The historical data trend for Infant Bacterial Therapeutics AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infant Bacterial Therapeutics AB Other Stockholders Equity Chart

Infant Bacterial Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

Infant Bacterial Therapeutics AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Infant Bacterial Therapeutics AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Infant Bacterial Therapeutics AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Infant Bacterial Therapeutics AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Infant Bacterial Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Infant Bacterial Therapeutics AB (OSTO:IBT B) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

9IB:Germany

Address

Bryggargatan 10, Stockholm, SWE, 111 21

Website

https://www.ibtherapeutics.com

Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118 and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.

Infant Bacterial Therapeutics AB Headlines

No Headlines